$NVR
NVR INC Stock $nvr

$nvr Overview Financials Valuation SEC Filings Company Website

2013 Q2 Form 10-Q Financial Statement

#000119312513310039 Filed on July 30, 2013

Income Statement

Concept	2013 Q2	2012 Q2
Revenue	$1.010B	$769.8M
YoY Change	31.19%	10.22%
Cost Of Revenue	$834.3M	$625.0M
YoY Change	33.49%	11.89%
Gross Profit	$177.9M	$146.3M
YoY Change	21.6%	4.65%
Gross Profit Margin	17.62%	19.01%
Selling, General & Admin	$92.40M	$82.10M
YoY Change	12.55%	8.17%
% of Gross Profit	51.94%	56.12%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$3.000M	$1.900M
YoY Change	57.89%	18.75%
% of Gross Profit	1.69%	1.3%
Operating Expenses	$92.40M	$82.10M
YoY Change	12.55%	8.17%
Operating Profit	$85.50M	$64.20M
YoY Change	33.18%	0.47%
Interest Expense	$5.374M	-$300.0K
YoY Change	-1891.33%	-50.0%
% of Operating Profit	6.29%	-0.47%
Other Income/Expense, Net
YoY Change
Pretax Income	$80.18M	$64.00M
YoY Change	25.28%	0.95%
Income Tax	$29.49M	$17.12M
% Of Pretax Income	36.78%	26.75%
Net Earnings	$50.69M	$46.84M
YoY Change	8.22%	21.83%
Net Earnings / Revenue	5.02%	6.08%
Basic Earnings Per Share	$10.37	$9.17
Diluted Earnings Per Share	$10.11	$8.97
COMMON SHARES
Basic Shares Outstanding	4.889M shares	5.106M shares
Diluted Shares Outstanding	5.013M shares	5.221M shares

Balance Sheet

Concept	2013 Q2	2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$777.3M	$592.7M
YoY Change	31.15%	-36.23%
Cash & Equivalents	$778.4M	$593.3M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory	$950.5M	$717.8M
Prepaid Expenses
Receivables	$14.80M	$9.600M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$1.743B	$1.320B
YoY Change	32.01%	-11.73%
LONG-TERM ASSETS
Property, Plant & Equipment	$32.70M	$27.10M
YoY Change	20.66%	10.16%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$788.6M	$670.9M
YoY Change	17.54%	-1.37%
TOTAL ASSETS
Total Short-Term Assets	$1.743B	$1.320B
Total Long-Term Assets	$788.6M	$670.9M
Total Assets	$2.531B	$1.991B
YoY Change	27.13%	-8.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$222.2M	$185.7M
YoY Change	19.66%	7.03%
Accrued Expenses	$248.0M	$190.4M
YoY Change	30.25%	3.14%
Deferred Revenue
YoY Change
Short-Term Debt	$1.600M	$1.100M
YoY Change	45.45%	-83.08%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$609.6M	$467.5M
YoY Change	30.4%	8.17%
LONG-TERM LIABILITIES
Long-Term Debt	$599.0M	$0.00
YoY Change		-100.0%
Other Long-Term Liabilities	$2.300M	$1.700M
YoY Change	35.29%	41.67%
Total Long-Term Liabilities	$601.3M	$1.700M
YoY Change	35270.59%	-98.16%
TOTAL LIABILITIES
Total Short-Term Liabilities	$609.6M	$467.5M
Total Long-Term Liabilities	$601.3M	$1.700M
Total Liabilities	$1.211B	$469.1M
YoY Change	158.13%	-10.63%
SHAREHOLDERS EQUITY
Retained Earnings	$4.425B
YoY Change
Common Stock	$1.197B
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$4.301B
YoY Change
Treasury Stock Shares	15.86M shares
Shareholders Equity	$1.320B	$1.522B
YoY Change
Total Liabilities & Shareholders Equity	$2.531B	$1.991B
YoY Change	27.13%	-8.49%

Cashflow Statement

Concept	2013 Q2	2012 Q2
OPERATING ACTIVITIES
Net Income	$50.69M	$46.84M
YoY Change	8.22%	21.83%
Depreciation, Depletion And Amortization	$3.000M	$1.900M
YoY Change	57.89%	18.75%
Cash From Operating Activities	-$12.40M	-$18.40M
YoY Change	-32.61%	13.58%
INVESTING ACTIVITIES
Capital Expenditures	-$4.600M	-$3.100M
YoY Change	48.39%	-52.31%
Acquisitions
YoY Change
Other Investing Activities	$2.000M	$1.100M
YoY Change	81.82%	-101.88%
Cash From Investing Activities	-$2.700M	-$2.000M
YoY Change	35.0%	-96.92%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-294.2M	38.60M
YoY Change	-862.18%	-118.5%
NET CHANGE
Cash From Operating Activities	-12.40M	-18.40M
Cash From Investing Activities	-2.700M	-2.000M
Cash From Financing Activities	-294.2M	38.60M
Net Change In Cash	-309.3M	18.20M
YoY Change	-1799.45%	-106.28%
FREE CASH FLOW
Cash From Operating Activities	-$12.40M	-$18.40M
Capital Expenditures	-$4.600M	-$3.100M
Free Cash Flow	-$7.800M	-$15.30M
YoY Change	-49.02%	57.73%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2012Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	60286000
CY2013Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	4633746	shares
CY2012Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	58790000
CY2012Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	593263000
CY2012Q2	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	0
CY2013Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	63057000
CY2013Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	1577000
CY2013Q2	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0395	pure
CY2013Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20555330	shares
CY2013Q2	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0397	pure
CY2013Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000	shares
CY2013Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	15855338	shares
CY2013Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2013Q2	us-gaap	Deferred Compensation Liability Current And Noncurrent DeferredCompensationLiabilityCurrentAndNoncurrent	17741000
CY2013Q2	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	754000
CY2013Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	77341000
CY2013Q2	us-gaap	Stockholders Equity StockholdersEquity	1320279000
CY2013Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1196385000
CY2013Q2	us-gaap	Non Recourse Debt NonRecourseDebt	1604000
CY2013Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	4424811000
CY2013Q2	us-gaap	Warehouse Agreement Borrowings WarehouseAgreementBorrowings	0
CY2013Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	600000000
CY2013Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	925000
CY2013Q2	us-gaap	Common Stock Value CommonStockValue	206000
CY2013Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2531167000
CY2013Q2	us-gaap	Liabilities Liabilities	1210888000
CY2013Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2013Q2	us-gaap	Common Stock Shares Held In Employee Trust CommonStockSharesHeldInEmployeeTrust	17741000
CY2013Q2	us-gaap	Assets Assets	2531167000
CY2013Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	778424000
CY2013Q2	us-gaap	Inventory Real Estate Land And Land Development Costs InventoryRealEstateLandAndLandDevelopmentCosts	87570000
CY2013Q2	nvr	Finished Lots Committed To Purchase FinishedLotsCommittedToPurchase	36	Lot
CY2013Q2	nvr	Loss Reserve On Contract Land Deposits LossReserveOnContractLandDeposits	61186000
CY2013Q2	nvr	Contingent Specific Performance Obligations ContingentSpecificPerformanceObligations	3125000
CY2013Q2	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	2454000
CY2013Q2	us-gaap	Deposits Assets DepositsAssets	207729000
CY2013Q2	us-gaap	Loans Held For Sale Mortgages LoansHeldForSaleMortgages	176285000
CY2013Q2	us-gaap	Variable Interest Entity Consolidated Carrying Amount Assets VariableInterestEntityConsolidatedCarryingAmountAssets	10209000
CY2013Q2	us-gaap	Treasury Stock Value TreasuryStockValue	4301123000
CY2013Q2	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	90800000
CY2013Q2	nvr	Land Under Development Related To Consolidated Joint Venture LandUnderDevelopmentRelatedToConsolidatedJointVenture	7774000
CY2013Q2	nvr	Power Of Developers Equity Holders To Direct Operating Activities Of Development Entity PowerOfDevelopersEquityHoldersToDirectOperatingActivitiesOfDevelopmentEntity	1.00	pure
CY2013Q2	nvr	Contract Land Deposits Risk Of Loss ContractLandDepositsRiskOfLoss	211608000
CY2013Q2	nvr	Other Assets Related To Consolidated Joint Venture OtherAssetsRelatedToConsolidatedJointVenture	855000
CY2013Q2	nvr	Number Of Finished Lots Intended To Be Developed From Raw Parcels Of Land NumberOfFinishedLotsIntendedToBeDevelopedFromRawParcelsOfLand	950	Lot
CY2013Q2	nvr	Number Of Joint Ventures NumberOfJointVentures	3	Joint_Ventures
CY2013Q2	nvr	Repurchase Facility Borrowing Base Limitations RepurchaseFacilityBorrowingBaseLimitations	0
CY2013Q2	nvr	Number Of Joint Ventures Company Is Not Primary Beneficiary NumberOfJointVenturesCompanyIsNotPrimaryBeneficiary	2	Joint_Ventures
CY2013Q2	nvr	Accrued Expenses Related To Consolidated Joint Venture AccruedExpensesRelatedToConsolidatedJointVenture	778000
CY2013Q2	nvr	Number Of Raw Parcels Of Land Acquired NumberOfRawParcelsOfLandAcquired	4	Parcels
CY2013Q2	nvr	Variable Interest Entity Consolidated Carrying Amount Liabilities And Equity VariableInterestEntityConsolidatedCarryingAmountLiabilitiesAndEquity	10209000
CY2013Q2	nvr	Equity Related To Consolidated Joint Venture EquityRelatedToConsolidatedJointVenture	7827000
CY2013Q2	nvr	Expiration Date Of Repurchase Agreement ExpirationDateOfRepurchaseAgreement	2014-07-30
CY2013Q2	nvr	Cash Related To Consolidated Joint Venture CashRelatedToConsolidatedJointVenture	1159000
CY2013Q2	nvr	Expected Production Of Finished Lots From Joint Ventures ExpectedProductionOfFinishedLotsFromJointVentures	7500	Lot
CY2013Q2	nvr	Contract Land Deposits ContractLandDeposits	268915000
CY2013Q2	nvr	Lots Controlled By Company LotsControlledByCompany	55500	Lot
CY2013Q2	nvr	Repurchase Facility Borrowing Capacity RepurchaseFacilityBorrowingCapacity	25000000
CY2013Q2	nvr	Restricted Cash Related To Consolidated Joint Venture RestrictedCashRelatedToConsolidatedJointVenture	421000
CY2013Q2	nvr	Deferred Compensation Trust Shares DeferredCompensationTrustShares	109256	shares
CY2013Q2	nvr	Fall Out Rate Of Measuring Fair Value Of Rate Lock Commitments FallOutRateOfMeasuringFairValueOfRateLockCommitments	0.09	pure
CY2013Q2	nvr	Maximum Percentage Of Deposits Required Under Purchase Agreements MaximumPercentageOfDepositsRequiredUnderPurchaseAgreements	0.10	pure
CY2013Q2	nvr	Average Basis Points Of Servicing Loan Amount AverageBasisPointsOfServicingLoanAmount	0.0080	pure
CY2013Q2	nvr	Letters Of Credit Related To Lots LettersOfCreditRelatedToLots	750000
CY2013Q2	nvr	Cash Deposited Related To Lots CashDepositedRelatedToLots	268900000
CY2013Q2	nvr	Valuation Allowance Of Contract Land Deposit Assets ValuationAllowanceOfContractLandDepositAssets	61200000
CY2011Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	64008000
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	480794000
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20556198	shares
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000	shares
CY2012Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	15642068	shares
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2012Q4	us-gaap	Deferred Compensation Liability Current And Noncurrent DeferredCompensationLiabilityCurrentAndNoncurrent	25331000
CY2012Q4	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	3338000
CY2012Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	62742000
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	1480477000
CY2012Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1169699000
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2012Q4	us-gaap	Goodwill Goodwill	441000
CY2012Q4	us-gaap	Common Stock Shares Held In Employee Trust CommonStockSharesHeldInEmployeeTrust	25331000
CY2012Q4	us-gaap	Assets Assets	2604842000
CY2012Q4	us-gaap	Non Recourse Debt NonRecourseDebt	4574000
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	4339080000
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	206000
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2604842000
CY2012Q4	us-gaap	Liabilities Liabilities	1124365000
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1153507000
CY2012Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	8778000
CY2012Q4	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	893000
CY2012Q4	us-gaap	Deposits Assets DepositsAssets	191538000
CY2012Q4	us-gaap	Variable Interest Entity Consolidated Carrying Amount Assets VariableInterestEntityConsolidatedCarryingAmountAssets	15626000
CY2012Q4	us-gaap	Treasury Stock Value TreasuryStockValue	4028508000
CY2012Q4	nvr	Land Under Development Related To Consolidated Joint Venture LandUnderDevelopmentRelatedToConsolidatedJointVenture	13382000
CY2012Q4	nvr	Finished Lots Committed To Purchase FinishedLotsCommittedToPurchase	71	Lot
CY2012Q4	nvr	Loss Reserve On Contract Land Deposits LossReserveOnContractLandDeposits	65039000
CY2012Q4	nvr	Contingent Specific Performance Obligations ContingentSpecificPerformanceObligations	7047000
CY2012Q4	nvr	Contract Land Deposits Risk Of Loss ContractLandDepositsRiskOfLoss	201923000
CY2012Q4	nvr	Other Assets Related To Consolidated Joint Venture OtherAssetsRelatedToConsolidatedJointVenture	833000
CY2012Q4	nvr	Accrued Expenses Related To Consolidated Joint Venture AccruedExpensesRelatedToConsolidatedJointVenture	935000
CY2012Q4	nvr	Variable Interest Entity Consolidated Carrying Amount Liabilities And Equity VariableInterestEntityConsolidatedCarryingAmountLiabilitiesAndEquity	15626000
CY2012Q4	nvr	Equity Related To Consolidated Joint Venture EquityRelatedToConsolidatedJointVenture	10117000
CY2012Q4	nvr	Cash Related To Consolidated Joint Venture CashRelatedToConsolidatedJointVenture	906000
CY2012Q4	nvr	Contract Land Deposits ContractLandDeposits	256577000
CY2012Q4	nvr	Lots Controlled By Company LotsControlledByCompany	53200	Lot
CY2012Q4	nvr	Restricted Cash Related To Consolidated Joint Venture RestrictedCashRelatedToConsolidatedJointVenture	505000
CY2012Q4	nvr	Deferred Compensation Trust Shares DeferredCompensationTrustShares	152223	shares
CY2012Q4	nvr	Letters Of Credit Related To Lots LettersOfCreditRelatedToLots	3300000
CY2012Q4	nvr	Cash Deposited Related To Lots CashDepositedRelatedToLots	256600000
CY2012Q4	nvr	Valuation Allowance Of Contract Land Deposit Assets ValuationAllowanceOfContractLandDepositAssets	65000000
	dei	Trading Symbol TradingSymbol	NVR
	dei	Entity Registrant Name EntityRegistrantName	NVR INC
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
	dei	Document Type DocumentType	10-Q
	dei	Document Period End Date DocumentPeriodEndDate	2013-06-30
	dei	Entity Central Index Key EntityCentralIndexKey	0000906163
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	us-gaap	Debt Instrument Date Of First Required Payment1 DebtInstrumentDateOfFirstRequiredPayment1	2013-03-15
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	16.92
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.1798	pure
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5067000	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	17.38
	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2022-09-15
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y3M15D
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	133000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	278.41
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0000	pure
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-90514000
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	300086	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.3272	pure
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4934000	shares
	us-gaap	Debt Instrument Frequency Of Periodic Payment DebtInstrumentFrequencyOfPeriodicPayment	Semi-annually in arrears on March 15 and September 15
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0042	pure
	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	87000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	136962	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0142	pure
	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P5Y
	us-gaap	Interest Paid Net InterestPaidNet	12607000
	us-gaap	Revenues Revenues	1780148000
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	12946000
	us-gaap	Gain Loss On Sale Of Mortgage Loans GainLossOnSaleOfMortgageLoans	28159000
	us-gaap	Increase Decrease In Deposits Outstanding IncreaseDecreaseInDepositsOutstanding	12204000
	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	23727000
	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	9230000
	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	11000000
	us-gaap	Real Estate Inventory Capitalized Interest Costs Cost Of Sales RealEstateInventoryCapitalizedInterestCostsCostOfSales	13000
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	9574000
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	5595000
	us-gaap	Net Income Loss NetIncomeLoss	85731000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	256541000
	us-gaap	Payments For Origination Of Mortgage Loans Held For Sale PaymentsForOriginationOfMortgageLoansHeldForSale	1032029000
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	18652000
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	294979000
	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	23727000
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	2970000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	8088000
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	18652000
	us-gaap	Interest Costs Incurred InterestCostsIncurred	12514000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-267862000
	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	2124000
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	294979000
	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	1334000
	us-gaap	Share Based Compensation ShareBasedCompensation	18652000
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-375083000
	us-gaap	Interest Expense InterestExpense	10940000
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	257000
	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	19304000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16707000
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	6671000
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	-3987000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5848000
	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0
	us-gaap	Proceeds From Sale Of Mortgage Loans Held For Sale ProceedsFromSaleOfMortgageLoansHeldForSale	1062075000
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	23727000
	us-gaap	Proceeds From Collection Of Mortgage Loans Held For Sale ProceedsFromCollectionOfMortgageLoansHeldForSale	943000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	49555000
	nvr	Fair Value Measurements Interest Rate Movement Effect FairValueMeasurementsInterestRateMovementEffect	-14067000
	nvr	Number Of Finished Lots Intended To Be Developed From Newly Acquired Raw Parcel Of Land NumberOfFinishedLotsIntendedToBeDevelopedFromNewlyAcquiredRawParcelOfLand	400	Lot
	nvr	Fair Value Measurement Assumed Gain Loss From Loan Sale FairValueMeasurementAssumedGainLossFromLoanSale	-2547000
	nvr	Income Loss From Continuing Operations Before Income Taxes IncomeLossFromContinuingOperationsBeforeIncomeTaxes	135286000
	nvr	Contract Land Deposit Asset Recovery ContractLandDepositAssetRecovery	4000000
	nvr	Fair Value Measurements Security Price Change Included In Earnings FairValueMeasurementsSecurityPriceChangeIncludedInEarnings	12810000
	nvr	Derivative Instruments Fair Value Adjustment Gain Loss DerivativeInstrumentsFairValueAdjustmentGainLoss	-20000
	nvr	Increase Decrease In Accounts Payable Customer Deposits And Accrued Expenses IncreaseDecreaseInAccountsPayableCustomerDepositsAndAccruedExpenses	106719000
	nvr	Corporate Capital Allocation Charge CorporateCapitalAllocationCharge	55291000
	nvr	Costs Accrued For New Warranty Contracts And Changes In Estimates For Pre Existing Warranties CostsAccruedForNewWarrantyContractsAndChangesInEstimatesForPreExistingWarranties	33903000
	nvr	Fair Value Measurements Changes In Servicing Rights Value FairValueMeasurementsChangesInServicingRightsValue	3784000
	nvr	Net Borrowings Repayments Under Note Payable And Credit Lines NetBorrowingsRepaymentsUnderNotePayableAndCreditLines	-311000
	nvr	Warranty Reserve Provision Single Completed Community WarrantyReserveProvisionSingleCompletedCommunity	15600000
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	12.90
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5191000	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	13.19
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	116000	shares
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	72391000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5075000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	479807	shares
	us-gaap	Interest Paid Net InterestPaidNet	587000
	us-gaap	Revenues Revenues	1370275000
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	15041000
	us-gaap	Gain Loss On Sale Of Mortgage Loans GainLossOnSaleOfMortgageLoans	21569000
	us-gaap	Increase Decrease In Deposits Outstanding IncreaseDecreaseInDepositsOutstanding	22770000
	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	4709000
	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	1000000
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	8273000
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	3005000
	us-gaap	Net Income Loss NetIncomeLoss	66961000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	164327000
	us-gaap	Payments For Origination Of Mortgage Loans Held For Sale PaymentsForOriginationOfMortgageLoansHeldForSale	880315000
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	4375000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5999000
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	33173000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	42393000
	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	4421000
	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	805000
	us-gaap	Share Based Compensation ShareBasedCompensation	33173000
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	112469000
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	263000
	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	20935000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2315000
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	42182000
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	-1160000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3730000
	us-gaap	Proceeds From Sale Of Mortgage Loans Held For Sale ProceedsFromSaleOfMortgageLoansHeldForSale	1001691000
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	4709000
	us-gaap	Proceeds From Collection Of Mortgage Loans Held For Sale ProceedsFromCollectionOfMortgageLoansHeldForSale	1612000
	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	442000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	27952000
	nvr	Income Loss From Continuing Operations Before Income Taxes IncomeLossFromContinuingOperationsBeforeIncomeTaxes	94913000
	nvr	Contract Land Deposit Asset Recovery ContractLandDepositAssetRecovery	1200000
	nvr	Increase Decrease In Accounts Payable Customer Deposits And Accrued Expenses IncreaseDecreaseInAccountsPayableCustomerDepositsAndAccruedExpenses	70547000
	nvr	Corporate Capital Allocation Charge CorporateCapitalAllocationCharge	41527000
	nvr	Costs Accrued For New Warranty Contracts And Changes In Estimates For Pre Existing Warranties CostsAccruedForNewWarrantyContractsAndChangesInEstimatesForPreExistingWarranties	15717000
	nvr	Net Borrowings Repayments Under Note Payable And Credit Lines NetBorrowingsRepaymentsUnderNotePayableAndCreditLines	-565000
CY2013Q1	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	11000000
CY2013Q1	nvr	Inventory Real Estate Land Acquisition Costs InventoryRealEstateLandAcquisitionCosts	28500000
CY2012Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	8.97
CY2012Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5221000	shares
CY2012Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	9.17
CY2012Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	115000	shares
CY2012Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5106000	shares
CY2012Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	160672	shares
CY2012Q2	us-gaap	Revenues Revenues	769783000
CY2012Q2	us-gaap	Net Income Loss NetIncomeLoss	46838000
CY2012Q2	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	16733000
CY2012Q2	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	10798000
CY2012Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	17117000
CY2012Q2	nvr	Income Loss From Continuing Operations Before Income Taxes IncomeLossFromContinuingOperationsBeforeIncomeTaxes	63955000
CY2012Q2	nvr	Contract Land Deposit Asset Recovery ContractLandDepositAssetRecovery	100000
CY2012Q2	nvr	Corporate Capital Allocation Charge CorporateCapitalAllocationCharge	22555000
CY2012Q2	nvr	Costs Accrued For New Warranty Contracts And Changes In Estimates For Pre Existing Warranties CostsAccruedForNewWarrantyContractsAndChangesInEstimatesForPreExistingWarranties	9302000
CY2013Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	10.11
CY2013Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5013000	shares
CY2013Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	10.37
CY2013Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	124000	shares
CY2013Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4889000	shares
CY2013Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	136962	shares
CY2013Q2	us-gaap	Revenues Revenues	1009892000
CY2013Q2	us-gaap	Real Estate Inventory Capitalized Interest Costs Cost Of Sales RealEstateInventoryCapitalizedInterestCostsCostOfSales	13000
CY2013Q2	us-gaap	Net Income Loss NetIncomeLoss	50690000
CY2013Q2	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	10589000
CY2013Q2	us-gaap	Interest Costs Incurred InterestCostsIncurred	6264000
CY2013Q2	us-gaap	Interest Expense InterestExpense	5374000
CY2013Q2	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	11328000
CY2013Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	29491000
CY2013Q2	nvr	Income Loss From Continuing Operations Before Income Taxes IncomeLossFromContinuingOperationsBeforeIncomeTaxes	80181000
CY2013Q2	nvr	Contract Land Deposit Asset Recovery ContractLandDepositAssetRecovery	3000000
CY2013Q2	nvr	Corporate Capital Allocation Charge CorporateCapitalAllocationCharge	29673000
CY2013Q2	nvr	Costs Accrued For New Warranty Contracts And Changes In Estimates For Pre Existing Warranties CostsAccruedForNewWarrantyContractsAndChangesInEstimatesForPreExistingWarranties	25612000
CY2013Q2	nvr	Warranty Reserve Provision Single Completed Community WarrantyReserveProvisionSingleCompletedCommunity	15600000

Files In Submission

Name	View Source	Status
0001193125-13-310039-index-headers.html	Edgar Link	pending
0001193125-13-310039-index.html	Edgar Link	pending
0001193125-13-310039.txt	Edgar Link	pending
0001193125-13-310039-xbrl.zip	Edgar Link	pending
d540338d10q.htm	Edgar Link	pending
d540338dex101.htm	Edgar Link	pending
d540338dex102.htm	Edgar Link	pending
d540338dex311.htm	Edgar Link	pending
d540338dex312.htm	Edgar Link	pending
d540338dex32.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
nvr-20130630.xml	Edgar Link	completed
nvr-20130630.xsd	Edgar Link	pending
nvr-20130630_cal.xml	Edgar Link	unprocessable
nvr-20130630_def.xml	Edgar Link	unprocessable
nvr-20130630_lab.xml	Edgar Link	unprocessable
nvr-20130630_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R1.xml	Edgar Link	unprocessable
R10.htm	Edgar Link	pending
R10.xml	Edgar Link	unprocessable
R11.htm	Edgar Link	pending
R11.xml	Edgar Link	unprocessable
R12.htm	Edgar Link	pending
R12.xml	Edgar Link	unprocessable
R13.htm	Edgar Link	pending
R13.xml	Edgar Link	unprocessable
R14.htm	Edgar Link	pending
R14.xml	Edgar Link	unprocessable
R15.htm	Edgar Link	pending
R15.xml	Edgar Link	unprocessable
R16.htm	Edgar Link	pending
R16.xml	Edgar Link	unprocessable
R17.htm	Edgar Link	pending
R17.xml	Edgar Link	unprocessable
R18.htm	Edgar Link	pending
R18.xml	Edgar Link	unprocessable
R19.htm	Edgar Link	pending
R19.xml	Edgar Link	unprocessable
R2.htm	Edgar Link	pending
R2.xml	Edgar Link	unprocessable
R20.htm	Edgar Link	pending
R20.xml	Edgar Link	unprocessable
R21.htm	Edgar Link	pending
R21.xml	Edgar Link	unprocessable
R22.htm	Edgar Link	pending
R22.xml	Edgar Link	unprocessable
R23.htm	Edgar Link	pending
R23.xml	Edgar Link	unprocessable
R24.htm	Edgar Link	pending
R24.xml	Edgar Link	unprocessable
R25.htm	Edgar Link	pending
R25.xml	Edgar Link	unprocessable
R26.htm	Edgar Link	pending
R26.xml	Edgar Link	unprocessable
R27.htm	Edgar Link	pending
R27.xml	Edgar Link	unprocessable
R28.htm	Edgar Link	pending
R28.xml	Edgar Link	unprocessable
R29.htm	Edgar Link	pending
R29.xml	Edgar Link	unprocessable
R3.htm	Edgar Link	pending
R3.xml	Edgar Link	unprocessable
R30.htm	Edgar Link	pending
R30.xml	Edgar Link	unprocessable
R31.htm	Edgar Link	pending
R31.xml	Edgar Link	unprocessable
R32.htm	Edgar Link	pending
R32.xml	Edgar Link	unprocessable
R33.htm	Edgar Link	pending
R33.xml	Edgar Link	unprocessable
R34.htm	Edgar Link	pending
R34.xml	Edgar Link	unprocessable
R35.htm	Edgar Link	pending
R35.xml	Edgar Link	unprocessable
R36.htm	Edgar Link	pending
R36.xml	Edgar Link	unprocessable
R37.htm	Edgar Link	pending
R37.xml	Edgar Link	unprocessable
R38.htm	Edgar Link	pending
R38.xml	Edgar Link	unprocessable
R39.htm	Edgar Link	pending
R39.xml	Edgar Link	unprocessable
R4.htm	Edgar Link	pending
R4.xml	Edgar Link	unprocessable
R40.htm	Edgar Link	pending
R40.xml	Edgar Link	unprocessable
R41.htm	Edgar Link	pending
R41.xml	Edgar Link	unprocessable
R42.htm	Edgar Link	pending
R42.xml	Edgar Link	unprocessable
R43.htm	Edgar Link	pending
R43.xml	Edgar Link	unprocessable
R44.htm	Edgar Link	pending
R44.xml	Edgar Link	unprocessable
R45.htm	Edgar Link	pending
R45.xml	Edgar Link	unprocessable
R46.htm	Edgar Link	pending
R46.xml	Edgar Link	unprocessable
R47.htm	Edgar Link	pending
R47.xml	Edgar Link	unprocessable
R48.htm	Edgar Link	pending
R48.xml	Edgar Link	unprocessable
R49.htm	Edgar Link	pending
R49.xml	Edgar Link	unprocessable
R5.htm	Edgar Link	pending
R5.xml	Edgar Link	unprocessable
R50.htm	Edgar Link	pending
R50.xml	Edgar Link	unprocessable
R51.htm	Edgar Link	pending
R51.xml	Edgar Link	unprocessable
R52.htm	Edgar Link	pending
R52.xml	Edgar Link	unprocessable
R53.htm	Edgar Link	pending
R53.xml	Edgar Link	unprocessable
R54.htm	Edgar Link	pending
R54.xml	Edgar Link	unprocessable
R55.htm	Edgar Link	pending
R55.xml	Edgar Link	unprocessable
R56.htm	Edgar Link	pending
R56.xml	Edgar Link	unprocessable
R6.htm	Edgar Link	pending
R6.xml	Edgar Link	unprocessable
R7.htm	Edgar Link	pending
R7.xml	Edgar Link	unprocessable
R8.htm	Edgar Link	pending
R8.xml	Edgar Link	unprocessable
R9.htm	Edgar Link	pending
R9.xml	Edgar Link	unprocessable
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NVR
NVR INC Stock $nvr

2013 Q2 Form 10-Q Financial Statement

#000119312513310039 Filed on July 30, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NVR NVR INC Stock $nvr

2013 Q2 Form 10-Q Financial Statement

#000119312513310039 Filed on July 30, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NVR
NVR INC Stock $nvr